Exocrine pancreatic insufficiency (EPI) occurs in chronic pancreatitis, cystic fibrosis, autoimmune disorders such as Crohn’s disease and systemic lupus erythematosus and patients that have had parts ...

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

is a condition in which systemic lupus erythematosus (SLE) affects the kidney, causing inflammation and damage. Renal disease develops early in SLE, with up to two-thirds of patients progressing to LN ...

Analyst Julian Harrison of BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), retaining the price target of ...

The primary objective is to evaluate the safety of CLN-978 for the treatment of active moderate to severe SLE, with secondary ...

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

Cullinan Therapeutics said the U.S. Food and Drug Administration approved its investigation new drug application for CLN-978, a potential treatment for lupus. The biopharmaceutical company said the ...

Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease ... significantly higher morbidity and mortality than adult-onset SLE. The traditional treatments for SLE ...

Doctors in Hangzhou, Zhejiang province, have successfully completed the world's largest clinical study of involving the use ...

Panelists discuss the considerations guiding treatment choices for lupus nephritis, such as drug interactions, patient characteristics, and steroid use, and how treatment approaches might differ ...

Neuropsychiatric systemic lupus erythematosus (NPSLE), or central nervous system lupus, can be challenging to diagnose ...